Device Trial Radar · NCT04515498
A Prospective Clinical Study of the CloudCath System During In-home Peritoneal Dialysis
Last checked: Nov 19, 2026Latest source record: May 30, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
243
Actual
Start
Aug 19, 2020
Primary completion
Mar 31, 2023
Study completion Mar 31, 2023
Sponsor
- Lead sponsor
- CloudCathNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 17, 2020
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to determine if the CloudCath device can detect infections related to peritoneal dialysis (peritonitis) as fast or faster than the current standard methods used by patients and doctors to detect such infections.
Conditions
- Peritoneal Dialysis-associated Peritonitis
Interventions
CloudCath Monitoring SystemDevice
The CloudCath Monitoring System will analyze effluent dialysate for changes associated with peritonitis.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time of peritonitis detection (vs lab measures)Time frame: through 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
CloudCath Investigational Site
Lakewood, Colorado
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.